Clinical Trial Update: Nab-paclitaxel and Gemcitabine vs Gemcitabine Alone as Adjuvant Therapy for Patients With Resected Pancreatic Cancer (the "Apact" Study) [Phase 3]

View source ↗

Summary

Phase 3 trial comparing nab-paclitaxel plus gemcitabine vs gemcitabine alone as adjuvant therapy for resected pancreatic cancer; completed with results posted i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Diseases
• Pancreatic Neoplasms

Drugs mentioned

• Gemcitabine (Gemcitabine)
• Nab-paclitaxel (paclitaxel protein-bound)

Snippet

Sponsor: Celgene | Conditions: Pancreatic Neoplasms, Digestive System Neoplasms | Phase 3 | Status: COMPLETED | Results posted: 2020-01-06